Overcoming resistance to endocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: A meta-analysis of randomized clinical trials-MedSci.cn

Overcoming resistance to endocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: A meta-analysis of randomized clinical trials

Zhu, W; Xu, B

ANNALS OF ONCOLOGY, 2020; 31 (): S74

科室
- - 订阅+
  - 更多科室
工具
服务